Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
European Archives of Oto-Rhino-Laryngology
Published in: European Archives of Oto-Rhino-Laryngology 11/2017

01-11-2017 | Review Article

Surgical options in benign parotid tumors: a proposal for classification

Authors: Miquel Quer, Vincent Vander Poorten, Robert P. Takes, Carl E. Silver, Carsten C. Boedeker, Remco de Bree, Alessandra Rinaldo, Alvaro Sanabria, Ashok R. Shaha, Albert Pujol, Peter Zbären, Alfio Ferlito

Published in: European Archives of Oto-Rhino-Laryngology | Issue 11/2017

Login to get access

Abstract

Different surgical options are currently available for treating benign tumors of the parotid gland, and the discussion on optimal treatment continues despite several meta-analyses. These options include more limited resections (extracapsular dissection, partial lateral parotidectomy) versus more extensive and traditional options (lateral parotid lobectomy, total parotidectomy). Different schools favor one option or another based on their experience, skills and tradition. This review provides a critical analysis of the literature regarding these options. The main limitation of all the studies is the bias of selection for different surgical approaches. For this reason, we propose a staging system that could facilitate clinical decision making and the comparison of results. We propose four categories based on the size of the tumor and its location within the parotid gland. Category I includes tumors up to 3 cm, which are mobile, close to the outer surface and close to the parotid borders. Category II includes deeper tumors up to 3 cm. Category III comprises tumors greater than 3 cm involving two levels of the parotid gland, and category IV tumors are greater than 3 cm and involve more than 2 levels. For each category and for the various pathologic types, a guideline of surgical extent is proposed. The objective of this classification is to facilitate prospective multicentric studies on surgical techniques in the treatment of benign parotid tumors and to enable the comparison of results of different clinical studies.
Literature
1.
Albergotti WG, Nguyen SA, Zenk J, Gillespie MB (2012) Extracapsular dissection for benign parotid tumors: a meta-analysis. Laryngoscope 122:1954–1960CrossRefPubMed
2.
Foresta E, Torroni A, Di Nardo F, de Waure C, Poscia A, Gasparini G, Marianetti TM, Pelo S (2014) Pleomorphic adenoma and benign parotid tumors: extracapsular dissection vs superficial parotidectomy—review of literature and meta-analysis. Oral Surg Oral Med Oral Pathol Oral Radiol 117:663–676CrossRefPubMed
3.
Xie S, Wang K, Xu H, Hua RX, Li TZ, Shan XF, Cai ZG (2015) PRISMA-extracapsular dissection versus superficial parotidectomy in treatment of benign parotid tumors: evidence from 3194 patients. Medicine (Baltimore) 94:e1237CrossRef
4.
Roh JL, Kim HS, Park CI (2007) Randomized clinical trial comparing partial parotidectomy versus superficial or total parotidectomy. Br J Surg 94:1081–1087CrossRefPubMed
5.
Zbären P, Vander Poorten V, Witt RL, Woolgar JA, Shaha AR, Triantafyllou A, Takes RP, Rinaldo A, Ferlito A (2013) Pleomorphic adenoma of the parotid: formal parotidectomy or limited surgery? Am J Surg 205:109–118CrossRefPubMed
6.
Triantafyllou A, Thompson LD, Devaney KO, Bell D, Hunt JL, Rinaldo A, Vander Poorten V, Ferlito A (2015) Functional histology of salivary gland pleomorphic adenoma: an appraisal. Head Neck Pathol 9:387–404CrossRefPubMed
7.
Johnson JT, Ferlito A, Fagan JJ, Bradley PJ, Rinaldo A (2007) Role of limited parotidectomy in management of pleomorphic adenoma. J Laryngol Otol 121:1126–1128PubMed
8.
Quer M, Guntinas-Lichius O, Marchal F, Vander Poorten V, Chevalier D, León X, Eisele D, Dulguerov P (2016) Classification of parotidectomies: a proposal of the European Salivary Gland Society. Eur Arch Otorhinolaryngol 273:3307–3312CrossRefPubMed
9.
Quer M, Pujol A, León X, López M, García J, Orús C, Sañudo JR (2010) Parotidectomías en tumores benignos: clasificación “Sant Pau” de la extensión de la resección. Acta Otorrinolaringol Esp 61:1–5CrossRefPubMed
10.
McFarland J (1936) Three hundred mixed tumors of the salivaryglands, of which sixty-nine recurred. Surg Gynecol Obstet 63:457–468
11.
Benedict EG, Meigs JV (1930) Tumors of the parotid gland: a study of 225 cases with complete end-results in 80 cases. Surg Gynecol Obstet 51:626–647
12.
Patey DH (1954) The present position of parotidectomy in the surgery of the parotid gland. Arch Middx Hosp 4:91–105PubMed
13.
Martin H (1952) The operative removal tumors of the parotid salivary gland. Surgery 31:670–682PubMed
14.
Laccourreye H, Laccourreye O, Cauchois R, Jouffre V, Menard M, Brasnu D (1994) Total conservative parotidectomy for primary benign pleomorphic adenoma of the parotid gland: a 25-year experience with 229 patients. Laryngoscope 104:1487–1494PubMed
15.
McEvedy MV, Ross WM (1976) The treatment of mixed parotid tumours by enucleation and radiotherapy. Br J Surg 63:341–342CrossRefPubMed
16.
Armitstead PR, Smiddy FG, Frank HG (1979) Simple enucleation and radiotherapy in the treatment of the pleomorphic salivary adenoma of the parotid gland. Br J Surg 66:716–717CrossRefPubMed
17.
Gleave EN, Whittaker JS, Nicholson A (1979) Salivary tumours—experience over thirty years. Clin Otolaryngol 4:247–257CrossRefPubMed
18.
19.
Vandenberg HJ Jr, Kambouris A, Pryzybylski T, Rachmaninoff N (1964) Salivary tumors: clinicopathologic review of 190 patients. Am J Surg 108:480–484CrossRefPubMed
20.
Yamashita T, Tomoda K, Kumazawa T (1993) The usefulness of partial parotidectomy for benign parotid gland tumors: a retrospective study of 306 cases. Acta Otolaryngol Suppl 500:113–116CrossRefPubMed
21.
Leverstein H, van der Wal JE, Tiwari RM, van der Waal I, Snow GB (1997) Surgical management of 246 previously untreated pleomorphic adenomas of the parotid gland. Br J Surg 84:399–403CrossRefPubMed
22.
O’Brien CJ, Malka VB, Mijailovic M (1993) Evaluation of 242 consecutive parotidectomies performed for benign and malignant disease. Aust N Z J Surg 63:870–877CrossRefPubMed
23.
Martis C (1983) Parotid benign tumors: comments on surgical treatment of 263 cases. Int J Oral Surg 12:211–220CrossRefPubMed
24.
Prichard AJ, Barton RP, Narula AA (1992) Complications of superficial parotidectomy versus extracapsular lumpectomy in the treatment of benign parotid lesions. J R Coll Surg Edinb 37:155–158PubMed
25.
Natvig K, Soberg R (1994) Relationship of intraoperative rupture of pleomorphic adenomas to recurrence: an 11–25 year follow-up study. Head Neck 16:213–217CrossRefPubMed
26.
Hancock BD (1999) Clinically benign parotid tumours: local dissection as an alternative to superficial parotidectomy in selected cases. Ann R Coll Surg Engl 81:299–301PubMedPubMedCentral
27.
Marti K, Zografos GC, Martis C (2000) Extracapsular excision of small benign tumors of the parotid gland. J Surg Oncol 75:208–209CrossRefPubMed
28.
Witt RL (2002) The significance of the margin in parotid surgery for pleomorphic adenoma. Laryngoscope 112:2141–2154CrossRefPubMed
29.
McGurk M, Thomas BL, Renehan AG (2003) Extracapsular dissection for clinically benign parotid lumps: reduced morbidity without oncological compromise. Br J Surg 89:1610–1613
30.
Uyar Y, Caglak F, Keles B, Yildirim G, Salturk Z (2011) Extracapsular dissection versus superficial parotidectomy in pleomorphic adenomas of the parotid gland. Kulak Burun Bogaz Ihtis Derg 21:76–79CrossRefPubMed
31.
Van Niekerk JL, Wobbes TH, Monstrey S, Bruaset I (1987) The management of parotid tumors: a ten-year experience. Acta Chir Belg 87:1–5PubMed
32.
McGurk M, Renehan A, Gleave EN, Hancock BD (1996) Clinical significance of the tumor capsule in the treatment of parotid adenomas. Br J Surg 83:1747–1749CrossRefPubMed
33.
Laskawi R, Schott T, Mirzaie-Petri M, Schroeder M (1996) Surgical management of pleomorphic adenomas of the parotid gland: a follow-up study of three methods. J Oral Maxillofac Surg 54:1176–1179CrossRefPubMed
34.
Leverstein H, Van Der Wal JE, Tiwari RM, Van Der Waal I, Snow GB (1997) Surgical management of 246 previously untreated pleomorphic adenomas of the parotid gland. Br J Surg 84:399–403CrossRefPubMed
35.
Henriksson G, Westrin KM, Carlsöö B, Silfverswärd C (1998) Recurrent primary pleomorphic adenomas of salivary gland origin: intrasurgical rupture, histopathologic features, and pseudopodia. Cancer 82:617–620CrossRefPubMed
36.
Ghosh S, Panarese A, Bull PD, Lee JA (2003) Marginally excised parotid pleomorphic salivary adenomas: risk factors for recurrence and management. A 12.5-year mean follow-up study of histologically marginal excisions. Clin Otolaryngol 28:262–266CrossRefPubMed
37.
O’Brien CJ (2003) Current management of benign parotid tumors: the role of limited superficial parotidectomy. Head Neck 25:946–952CrossRefPubMed
38.
Piekarski J, Nejc D, Szymczak W, Wronski K, Jeziorski A (2004) Results of extracapsular dissection of pleomorphic adenoma of parotid gland. J Oral Maxillofac Surg 62:1198–1202CrossRefPubMed
39.
Guntinas-Lichius O, Kick C, Klussmann JP, Jungehuelsing M, Stennert E (2004) Pleomorphic adenoma of the parotid gland: a 13-year experience of consequent management by lateral or total parotidectomy. Eur Arch Otorhinolaryngol 261:143–146CrossRefPubMed
40.
Guntinas-Lichius O, Klussmann JP, Wittekindt C, Stennert E (2006) Parotidectomy for benign parotid disease at a university teaching hospital: outcome of 963 operations. Laryngoscope 116:534–540CrossRefPubMed
41.
Smith S, Komisar A (2007) Limited parotidectomy: the role of extracapsular dissection in parotid gland neoplasms. Laryngoscope 117:1163–1167CrossRefPubMed
42.
Takahama Junior A, Almeida OP, Kowalski LP (2009) Parotid neoplasms: analysis of 600 patients attended at a single institution. Braz J Otorhinolaryngol. 75:497–501CrossRefPubMed
43.
Chan WH, Lee KW, Chiang FY, Ho KY, Chai CY, Kuo WR (2010) Features of parotid gland disease and surgical results in Southern Taiwan. Kaohsiung J Med Sci 26:483–492CrossRefPubMed
44.
Shehata EA (2010) Extracapsular dissection for benign parotid tumours. Int J Oral Maxillofac Surg 39:140–144CrossRefPubMed
45.
Riad MA, Abdel-Rahman H, Ezzat WF, Adly A, Dessouky O, Shehata M (2011) Variables related to recurrence of pleomorphic adenomas: outcome of parotid surgery in 182 cases. Laryngoscope 121:1467–1472CrossRefPubMed
46.
47.
Zhang SS, Ma DQ, Guo CB et al (2013) Conservation of salivary secretion and facial nerve function in partial superficial parotidectomy. Int J Oral Maxillofac Surg 42:868–873CrossRefPubMed
48.
Orabona GD, Bonavolonta P, Iaconetta G et al (2013) Surgical management of benign tumors of the parotid gland: extracapsular dissection versus superficial parotidectomy-our experience in 232 cases. J Oral Maxil Surg 71:410–413CrossRef
49.
Iro H, Zenk J, Koch M et al (2013) Follow-up of parotid pleomorphic adenomas treated by extracapsular dissection. Head Neck 35:788–793CrossRefPubMed
50.
Huang G, Yan G, Wei X et al (2015) Superficial parotidectomy versus partial superficial parotidectomy in treating benign parotid tumors. Oncol Lett 9:887–890PubMed
51.
Witt RL, Rejto L (2009) Pleomorphic adenoma: extracapsular dissection versus partial superficial parotidectomy with facial nerve dissection. Del Med J 81:119–125PubMed
52.
Cristofaro MG, Allegra E, Giudice A, Colangeli W, Caruso D, Barca I, Giudice M (2014) Pleomorphic adenoma of the parotid: extracapsular dissection compared with superficial parotidectomy—a 10-year retrospective cohort study. Sci World J 2014:564053CrossRef
53.
Kadletz L, Grasl S, Grasl MC, Perisanidis C, Erovic BM (2017) Extracapsular dissection versus superficial parotidectomy in benign parotid gland tumors: the Vienna Medical School experience. Head Neck 39:356–360CrossRefPubMed
54.
Medberya R, Yousemb DM, Needhama MF, Kligermana MM (2000) Variation in parotid gland size, configuration, and anatomic relations. Radiother Oncol 54:87–89CrossRef
55.
El-Nagar AK, Chan JKC, Grandis JR, Takata T, Slootweg PJ (eds) (2017) World Health Organization classification of head and neck tumours, 4th edn. IARC Press, Lyon
56.
Espinoza S, Felter A, Malinvaud D, Badoual C, Chatellier G, Siauve N, Halimi P (2016) Warthin’s tumor of parotid gland: surgery or follow-up? Diagnostic value of a decisional algorithm with functional MRI. Diagn Interv Imaging 97:37–43CrossRefPubMed
57.
Ethunandan M, Pratt CA, Higgins B, Morrison A, Umar T, Macpherson DW, Wilson AW (2008) Factors influencing the occurrence of multicentric and ‘recurrent’ Warthin’s tumour: a cross sectional study. Int J Oral Maxillofac Surg 37:831–834CrossRefPubMed
58.
Schwalje AT, Uzelac A, Ryan WR (2015) Growth rate characteristics of Warthin’s tumours of the parotid gland. Int J Oral Maxillofac Surg 44:1474–1479CrossRefPubMed
59.
Witt RL, Iacocca M, Gerges F (2015) Contemporary diagnosis and management of Warthin’s tumor. Del Med J 87:13–16PubMed
60.
Thangarajah T, Reddy VM, Castellanos-Arango F, Panarese A (2009) Current controversies in the management of Warthin tumour. Postgrad Med J 85:3–8CrossRefPubMed
61.
Reddy VM, Thangarajah T, Castellanos-Arango F, Panarese A (2008) Conservative management of Warthin tumour. J Otolaryngol Head Neck Surg 37:744–749PubMed
62.
Iwai H, Yamashita T (2005) Local excision procedure for Warthin’s tumor of the parotid gland. Otolaryngol Head Neck Surg 132:577–580CrossRefPubMed
63.
Leverstein H, Van der Wal JE, Tiwari RM, Van der Waal I, Snow GB (1997) Results of the surgical management and histopathological evaluation of 88 parotid gland Warthin’s tumours. Clin Otolaryngol Allied Sci 22:500–503CrossRefPubMed
64.
Peter Klussmann J, Wittekindt C, Florian Preuss S, Al Attab A, Schroeder U, Guntinas-Lichius O (2006) High risk for bilateral Warthin tumor in heavy smokers—review of 185 cases. Acta Otolaryngol 126:1213–1217CrossRefPubMed
65.
Domenick NA, Johnson JT (2011) Parotid tumor size predicts proximity to the facial nerve. Laryngoscope 121:2366–2370CrossRefPubMed
66.
Ichihara T, Kawata R, Higashino M, Terada T, Haginomori S (2014) A more appropriate clinical classification of benign parotid tumors: investigation of 425 cases. Acta Otolaryngol 134:1185–1191CrossRefPubMed
67.
Witt RL, Eisele DW, Morton RP, Nicolai P, Poorten VV, Zbären P (2015) Etiology and management of recurrent parotid pleomorphic adenoma. Laryngoscope 125:888–893CrossRefPubMed
68.
Wittekindt C, Streubel K, Arnold G, Stennert E, Guntinas-Lichius O (2007) Recurrent pleomorphic adenoma of the parotid gland: analysis of 108 consecutive patients. Head Neck 29:822–828CrossRefPubMed
69.
Mantsopoulos K, Koch M, Klintworth N, Zenk J, Iro H (2015) Evolution and changing trends in surgery for benign parotid tumors. Laryngoscope 125:122–127CrossRefPubMed
70.
Mantsopoulos K, Scherl C, Iro H (2017) Investigation of arguments against properly indicated extracapsular dissection in the parotid gland. Head Neck 39:498–502CrossRefPubMed
71.
Silvoniemi A, Pulkkinen J, Grénman R (2010) Parotidectomy in the treatment of pleomorphic adenoma—analysis of long-term results. Acta Otolaryngol 130:1300–1305CrossRefPubMed
72.
Vlantis AC, Ng SK, Mak CK, Cheung JM, Chan AB, van Hasselt CA (2016) If cytology of Warthin tumor is accurate, can management be conservative? Ear Nose Throat J 95:185–188PubMed
73.
74.
Witt RL (2016) Extracapsular dissection with facial nerve dissection for benign parotid tumors. Otolaryngol Head Neck Surg 154:572–574CrossRefPubMed
75.
Scarpini M, Amore Bonapasta S, Ruperto M, Vestri A, Bononi M, Caporale A et al (2009) Retrograde parotidectomy for pleomorphic adenoma of the parotid gland: a conservative and effective approach. J Craniofac Surg 20:967–969CrossRefPubMed
76.
Postema RJ, van Velthuysen ML, van den Brekel MW, Balm AJ, Peterse JL (2004) Accuracy of fine-needle aspiration cytology of salivary gland lesions in the netherlands cancer institute. Head Neck 26:418–424CrossRefPubMed
Metadata
Title
Surgical options in benign parotid tumors: a proposal for classification
Authors
Miquel Quer
Vincent Vander Poorten
Robert P. Takes
Carl E. Silver
Carsten C. Boedeker
Remco de Bree
Alessandra Rinaldo
Alvaro Sanabria
Ashok R. Shaha
Albert Pujol
Peter Zbären
Alfio Ferlito
Publication date
01-11-2017
Publisher
Springer Berlin Heidelberg
Published in
European Archives of Oto-Rhino-Laryngology / Issue 11/2017
Print ISSN: 0937-4477
Electronic ISSN: 1434-4726
DOI
https://doi.org/10.1007/s00405-017-4650-4

Other articles of this Issue 11/2017

European Archives of Oto-Rhino-Laryngology 11/2017 Go to the issue

Head and Neck

MDCT of the temporal bone and audiological findings of pediatric acquired cholesteatoma

Miscellaneous

Transoral robotic-assisted surgery for the approach to anterior cervical spine lesions

Laryngology

Association of breathing sound spectra with glottal dimensions in exercise-induced vocal cord dysfunction

Review Article

The role of high-risk human papillomavirus infections in laryngeal squamous cell carcinoma

Letter to the Editor

Author’s reply to a letter-to-the-editor about the paper ‘Eardrum thickening approach for the treatment of patulous Eustachian tube’

Head and Neck

The presence of minor salivary glands in the peritonsillar space